Pharmaceutical News

RSS

EpiCept, Meda enter into exclusive commercialization agreement for Ceplene

EpiCept Corporation announced today that it has entered into an exclusive commercialization agreement for Ceplene® (histamine dihydrochloride) with Meda AB, a leading international specialty pharmaceutical company based in Stockholm. Ceplene is EpiCept’s novel therapy approved in the European Union with orphan drug status for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first remission.

11 Jan 2010

Bryant Ranch Prepack tracks medications from its manufacture to the patient with E Pedigree

“More and more physicians are realizing that prescriptions that leave the office are like money walking out of the door,” said Fred Ganjian, Vice President of Sales and Marketing for Bryant Ranch Prepack, a leading supplier of prepackaged physician-dispensed prescription programs. “In this day of continuing pressure on physicians to cover their costs, physician-dispensed prescriptions have become increasingly important to a physician’s bottom line,” he added.

11 Jan 2010

Highmark joins with CDC to promote National Influenza Vaccination Week

Beginning Sunday, Jan. 10 and continuing through the week, Highmark Inc. will join with the Centers for Disease Control (CDC) to promote National Influenza Vaccination Week.

10 Jan 2010

AMAG Pharmaceuticals provides update on the commercial launch of Feraheme Injection

AMAG Pharmaceuticals, Inc. today provided an update on the commercial launch of Feraheme® (ferumoxytol) Injection for intravenous (IV) use, including preliminary fourth quarter 2009 Feraheme net product revenues estimates, as well as an update on the Company’s international and label expansion efforts.

10 Jan 2010

Thirteen percent of poison exposure calls related to painkillers

U.S. poison centers answered more than 4.3 million calls in 2008, including nearly 2.5 million calls about human exposures to poison, according to the American Association of Poison Control Centers -- up from 4.2 million calls in 2007.

9 Jan 2010

Selection of therapeutic workshops to be presented at the Twelfth Annual BIO CEO & Investor Conference

“This year’s BIO CEO & Investor Conference will provide a unique forum to showcase therapeutic areas with key catalysts – from new and dynamic therapies to cutting edge investment opportunities,” said Alan Eisenberg, executive vice president of Emerging Companies & Business Development at BIO.

9 Jan 2010

Americans encouraged to get H1N1 flu vaccine during National Influenza Vaccination Week

The U.S. Department of Health and Human Services (HHS) and its Centers for Disease Control and Prevention (CDC) announced a nationwide effort to encourage more Americans to get the H1N1 flu vaccine during National Influenza Vaccination Week, January 10–16, 2010.

9 Jan 2010

Results of randomized, placebo-controlled study of Ambrotose complex announced

Mannatech, Incorporated, a global pioneer in the development of high-quality health, weight and fitness, and skin care solutions based on nutritional science, announced the results of a randomized, double-blind, placebo-controlled study that shows healthy middle-aged adults who took one teaspoon of Ambrotose® complex twice daily performed significantly better on memory tasks and were overall more positive in their mood.

9 Jan 2010

Illicit drug use among older adults may lead to increase in substance abuse treatment services

A new study done by the Substance Abuse and Mental Health Services Administration (SAMHSA) indicates that the aging of the baby boom generation is resulting in a dramatic increase in levels of illicit drug use among adults 50 and older. These increases may require the doubling of substance abuse treatment services needed for this population by 2020, according to the report.

9 Jan 2010

Recent releases in Global Health

A Lancet Comment examines the "grossly insufficient" progress towards meeting the Millennium Development Goal (MDG) of reducing under-5 child mortality. "Accelerated progress can be achieved, even in the poorest environments, through: integrated, evidence-driven, and community-based programmes that focus on addressing the major causes of death, including pneumonia, diarrhoea, newborn disorders, malaria, HIV, and undernutrition; reaching the unreached with a basic package of interventions at large scale and achieving coverage with equity; and using data for action and advocacy," the comment concludes (You et al., 1/9).

9 Jan 2010

AIIRA/CCB drug combination provides superior safety and efficacy compared to other fixed-dose combinations

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a hypertension drug that requires less-frequent dosing than Novartis's Diovan/Tareg (valsartan) would earn 30 percent patient share according to surveyed U.S. cardiologists

9 Jan 2010

FDA yet to review MannKind’s NDA for insulin therapy

MannKind Corporation announced that it was informed today by the Food and Drug Administration that the FDA will not be able to complete the review of MannKind’s new drug application (NDA) for its ultra rapid-acting insulin therapy by the action date of January 16, 2010.

9 Jan 2010

Green Cross seeks regulatory approval for peramivir in S.Korea

BioCryst Pharmaceuticals, Inc. today announced that it has been informed by its partner, Green Cross Corp., that Green Cross has filed a New Drug Application (NDA) in South Korea to seek regulatory approval for intravenous (i.v.) peramivir to treat patients with influenza.

9 Jan 2010

Centron receives agency of record assignments for FRAGMIN and GLIADEL Wafer medicines

HealthSTAR's Centron, a medical communications company, is pleased to announce that they have been awarded agency of record assignments for FRAGMIN® and GLIADEL® Wafer from Eisai Inc.

9 Jan 2010

Watson Pharmaceuticals files ANDA with FDA seeking approval to market LoSeasonique

Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its levonorgestrel and ethinyl estradiol (0.10 mg/0.02 mg) oral contraceptive product prior to the expiration of U.S. Patent No. 7,615,545, which is owned by Duramed Pharmaceuticals, Inc., a subsidiary of Teva Pharmaceutical Industries, Ltd.

9 Jan 2010

Genentech's ACTEMRA approved to treat RA

Genentech, Inc., a wholly owned member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approved ACTEMRA® (tocilizumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies.

8 Jan 2010

CDC encourages public to receive H1N1 vaccine; PBS examines arrival of vaccine in developing countries

During a media briefing Thursday, Anne Schuchat, director of the National Center for Immunization and Respiratory Diseases at the CDC, warned against complacency over the H1N1 (swine flu), and encouraged Americans who had not yet received the H1N1 vaccine to do so, CNN reports.

8 Jan 2010

ESF-UB Conference to concentrate on potentially clinically relevant polymorphisms

Pharmacogenetics started in the fifties with the discovery of primaquine-related haemolysis among glucose-6-phosphate deshydrogenase deficient patients. At the end of the century, it progressively evolved into Pharmacogenomics, investigating simultaneously multiple gene targets till covering the whole genome in relation with altered drug response.

8 Jan 2010

Prolia drug expected to garner blockbuster sales in 2018

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite the U.S. Food and Drug Administration's (FDA) recent request for postmarketing surveillance of Amgen's Prolia, the drug's expected launch this year in the United States and Europe for the treatment of osteoporosis will drive Prolia to garner blockbuster sales in 2018..

8 Jan 2010

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

Chinese researchers have become the world's fifth most prolific contributors to peer-reviewed scientific literature on clock-reversing regenerative medicine even as a skeptical international research community condemns the practice of Chinese clinics administering unproven stem cell therapies to domestic and foreign patients.

8 Jan 2010

Pharmaceutical News

EpiCept, Meda enter into exclusive commercialization agreement for Ceplene

Bryant Ranch Prepack tracks medications from its manufacture to the patient with E Pedigree

Highmark joins with CDC to promote National Influenza Vaccination Week

AMAG Pharmaceuticals provides update on the commercial launch of Feraheme Injection

Thirteen percent of poison exposure calls related to painkillers

Selection of therapeutic workshops to be presented at the Twelfth Annual BIO CEO & Investor Conference

Americans encouraged to get H1N1 flu vaccine during National Influenza Vaccination Week

Results of randomized, placebo-controlled study of Ambrotose complex announced

Illicit drug use among older adults may lead to increase in substance abuse treatment services

Recent releases in Global Health

AIIRA/CCB drug combination provides superior safety and efficacy compared to other fixed-dose combinations

FDA yet to review MannKind’s NDA for insulin therapy

Green Cross seeks regulatory approval for peramivir in S.Korea

Centron receives agency of record assignments for FRAGMIN and GLIADEL Wafer medicines

Watson Pharmaceuticals files ANDA with FDA seeking approval to market LoSeasonique

Genentech's ACTEMRA approved to treat RA

CDC encourages public to receive H1N1 vaccine; PBS examines arrival of vaccine in developing countries

ESF-UB Conference to concentrate on potentially clinically relevant polymorphisms

Prolia drug expected to garner blockbuster sales in 2018

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News